187 related articles for article (PubMed ID: 27470391)
1. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.
Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B
Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391
[TBL] [Abstract][Full Text] [Related]
2. A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA in the pathogenesis and prognosis of esophageal cancer.
Gu J; Wang Y; Wu X
Curr Pharm Des; 2013; 19(7):1292-300. PubMed ID: 23092349
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus.
Bansal A; Gupta V; Wang K
J Cell Biochem; 2016 Jun; 117(6):1288-95. PubMed ID: 26808728
[TBL] [Abstract][Full Text] [Related]
6. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.
Kestens C; Siersema PD; van Baal JW
World J Gastroenterol; 2016 Jan; 22(1):1-7. PubMed ID: 26755856
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.
Huang J; Zhang SY; Gao YM; Liu YF; Liu YB; Zhao ZG; Yang K
Cell Prolif; 2014 Aug; 47(4):277-86. PubMed ID: 24909356
[TBL] [Abstract][Full Text] [Related]
8. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
9. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma.
Zarrilli G; Galuppini F; Angerilli V; Munari G; Sabbadin M; Lazzarin V; Nicolè L; Biancotti R; Fassan M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807389
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
Bobryshev YV; Orekhov AN; Chistiakov DA
Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options.
Fassan M; Baffa R; Kiss A; Zaninotto G; Rugge M
Curr Pharm Des; 2013; 19(7):1236-41. PubMed ID: 23092347
[TBL] [Abstract][Full Text] [Related]
12. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ
Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872
[TBL] [Abstract][Full Text] [Related]
13. miRNA-mRNA crosstalk in esophageal cancer: From diagnosis to therapy.
Sharma P; Sharma R
Crit Rev Oncol Hematol; 2015 Dec; 96(3):449-62. PubMed ID: 26257289
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.
Yang W; Ma J; Zhou W; Zhou X; Cao B; Zhang H; Zhao Q; Fan D; Hong L
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1151-1163. PubMed ID: 28838272
[TBL] [Abstract][Full Text] [Related]
15. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and esophageal cancer--implications for pathogenesis and therapy.
Mayne GC; Hussey DJ; Watson DI
Curr Pharm Des; 2013; 19(7):1211-26. PubMed ID: 23092342
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer.
Hou X; Wen J; Ren Z; Zhang G
Oncotarget; 2017 Jun; 8(26):43571-43578. PubMed ID: 28388588
[TBL] [Abstract][Full Text] [Related]
20. MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance.
Derouet MF; Liu G; Darling GE
PLoS One; 2014; 9(12):e115589. PubMed ID: 25551563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
